Positron Emission Tomography/Computed Tomography Transformation of Oncology: Multiple Myeloma.
PET Clin
; 19(2): 249-260, 2024 Apr.
Article
in En
| MEDLINE
| ID: mdl-38199914
ABSTRACT
This article provides a comprehensive review of the role of 2-deoxy-2-[18F]fluoro-d-glucose (18F FDG) positron emission tomography/computed tomography (PET/CT) in multiple myeloma (MM) and related plasma cell disorders. MM is a hematologic malignancy characterized by the neoplastic proliferation of plasma cells. 18F FDG PET/CT integrates metabolic and anatomic information, allowing for accurate localization of metabolically active disease. The article discusses the use of 18F FDG PET/CT in initial diagnosis, staging, prognostication, and assessing treatment response. Additionally, it provides valuable insights into the novel imaging targets including chemokine receptor C-X-C motif 4 and CD38.
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Positron Emission Tomography Computed Tomography
/
Multiple Myeloma
Limits:
Humans
Language:
En
Journal:
PET Clin
Year:
2024
Document type:
Article
Affiliation country: